Respect for your privacy is our priority

The cookie is a small information file stored in your browser each time you visit our web page.

Cookies are useful because they record the history of your activity on our web page. Thus, when you return to the page, it identifies you and configures its content based on your browsing habits, your identity and your preferences.

You may accept cookies or refuse, block or delete cookies, at your convenience. To do this, you can choose from one of the options available on this window or even and if necessary, by configuring your browser.

If you refuse cookies, we can not guarantee the proper functioning of the various features of our web page.

For more information, please read the COOKIES INFORMATION section on our web page.


Webinar: Tomato Products, Blood Health and Labelling

09/03/2021 - Press release
Tomato News hosted a Tomato Foundation webinar on the 25th February, providing a complete update on the tomato products sample study carried out at SSICA. Coordinated by the Foundation’s president, Gwen Young, the webinar featured a presentation from Dr. Luca Sandei, scientific leader at SSICA. His presentation covered the outcome data taken from over 100 samples, in triplicate, provided by 18 companies from around the world.
The aim of the study was to evaluate the presence and concentrations of a list of compounds found in normal everyday tomato products also known to be the active components in a tomato supplement called Fruitflow. This supplement already has an EFSA health claim for improved blood flow or anti-thrombotic effect.
Dr. Sandei presented results showing normal servings of almost all tomato products contain these same compounds at similar or much higher levels than a single daily dose of the supplement.
Additionally, data was presented on the analysis of Vitamin E and Potassium content in the samples. There are currently existing EFSA health claims for these compounds and many tomato products qualify to use them.
Tomato Foundation founder, David Sutherland, presented the plan for the next steps in the research. The aim is to immediately begin preparing scientific papers for publication in peer-reviewed journals and to use the article abstracts to initiate a communications campaign. Also, to prepare funding applications for EU funding streams to advance the clinical trials necessary to continue the Foundation’s Health Claim project, to successfully gain a health claim for improved blood flow.
Mr. Sutherland illustrated the benefit to the tomato industry really lies in providing a benefit to consumers first in the form of reliable, independent research on topics directly relevant to consumers’ lives.
He went on to outline a plan for the Foundation to provide the processing tomato industry with a document that explains the regulations for use of the EFSA health claims for Vitamin E and Potassium and how they relate to some other territories for labelling information and possible wording. This will be ready by April.
Presenting the short-term plan for this year, Mr. Sutherland thanked current partners and appealed to the industry globally for continued economic support of the Foundation to progress the work and build on previous successes. 
For anyone who was unable to attend the webinar, a video recording is available here

Source: The Tomato Foundation 
Related events

Tomato Products, Blood Health and Labelling - Insights from the Tomato Foundation sample study data

25/02/2021 to 25/02/2021
The results of the Tomato Foundation sample study to determine how tomato products could qualify for an EFSA health claim and the foundation...
See details
Related companies


Research organisation See details

The Tomato Foundation

Professional or non-profit organisation See details
Related researchers

Dr. Luca Sandei


See details





Supporting partners
Featured company
Most popular news
Featured event
2022 Tomato News Conference
Our supporting partners